Product Information
CIPROFLOXACIN HCL 250 MG TAB is a generic product labeled by Chartwell RX LLC, priced at $0.0842 per EA under NDC 62135030801. Its NADAC has been published 264 times since Jun 9, 2021.
Strength
250 mg/1
Manufacturer
Chartwell RX LLCNDC
62135030801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076896On Market Since
4/13/2021
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACIN HCL 250 MG TAB has been published 264 times since Jun 9, 2021, and over the history we have for it it has declined 19.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0842 per EA |
|---|---|
| All-time high | $0.1077 (Sep 15, 2021) |
| All-time low | $0.0811 (Nov 20, 2024) |
| 52-week high | $0.0917 |
| 52-week low | $0.0842 |
| Median price | $0.0940 |
| Average price | $0.0943 |
| Largest weekly change | -21.4% (Apr 17, 2024) |
| Weeks tracked | 264 |
| Tracking since | Jun 9, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Ciprofloxacin hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CIPROFLOXACIN HCL 250 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN HCL 250 MG TAB, manufactured by Chartwell RX LLC, is $0.0842 per EA (NDC 62135030801), effective Jun 24, 2026.
How has the price of CIPROFLOXACIN HCL 250 MG TAB changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has declined 19.5%. It has been tracked across 264 weekly CMS publications since Jun 9, 2021.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN HCL 250 MG TAB?
Since Jun 9, 2021, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has ranged from a low of $0.0811 (Nov 20, 2024) to a high of $0.1077 (Sep 15, 2021), with a median of $0.0940 per EA.
Are there cheaper alternatives to CIPROFLOXACIN HCL 250 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CIPROFLOXACIN HCL 250 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures CIPROFLOXACIN HCL 250 MG TAB?
CIPROFLOXACIN HCL 250 MG TAB (NDC 62135030801) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification